FLVCR2
Basic information
Region (hg38): 14:75578620-75663214
Previous symbols: [ "C14orf58" ]
Links
Phenotypes
GenCC
Source:
- Fowler syndrome (Definitive), mode of inheritance: AR
- Fowler syndrome (Strong), mode of inheritance: AR
- Fowler syndrome (Moderate), mode of inheritance: AR
- Fowler syndrome (Strong), mode of inheritance: AR
- Fowler syndrome (Strong), mode of inheritance: AR
- Fowler syndrome (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome | AR | General | Treatment may involve dietary modification (eg, to restrict trimethylamine precursors), and medical/dietary treatment (eg, with agents such as metronidazole, neomycin, lactulose, copper chlorphyllin, activated charcoal, (E, E)-2, 4-undecadienal) as well as riboflavin supplementation (the use of specific pH soaps may be beneficial as well) | Cardiovascular; Craniofacial; Musculoskeletal; Neurologic | 7474897; 9398858; 9846928; 10646019; 10485731; 12653714; 12893987; 12938085; 15565078; 16601883; 20301282; 22126753; 23430514 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FLVCR2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 21 | 29 | ||||
missense | 50 | 57 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 3 | 4 | |||
non coding | 26 | 22 | 24 | 72 | ||
Total | 3 | 3 | 84 | 49 | 30 |
Highest pathogenic variant AF is 0.0000395
Variants in FLVCR2
This is a list of pathogenic ClinVar variants found in the FLVCR2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-75578850-GTC-G | Fowler syndrome | Benign (Nov 26, 2021) | ||
14-75578862-T-C | Posterior column ataxia-retinitis pigmentosa syndrome | Benign/Likely benign (Dec 13, 2019) | ||
14-75578877-T-C | Posterior column ataxia-retinitis pigmentosa syndrome | Benign (Nov 11, 2018) | ||
14-75578902-C-T | Posterior column ataxia-retinitis pigmentosa syndrome | Benign (Nov 23, 2019) | ||
14-75578980-A-G | Inborn genetic diseases | Uncertain significance (Oct 01, 2022) | ||
14-75579019-T-C | not specified • Posterior column ataxia-retinitis pigmentosa syndrome • Fowler syndrome | Benign (Jan 29, 2024) | ||
14-75579022-C-CG | Fowler syndrome | Pathogenic/Likely pathogenic (Sep 14, 2023) | ||
14-75579023-G-A | Likely benign (Nov 27, 2023) | |||
14-75579041-G-A | Posterior column ataxia-retinitis pigmentosa syndrome | Uncertain significance (Jan 13, 2018) | ||
14-75579044-CCCCAGCGTCTCGGTCCAT-C | FLVCR2-related disorder | Likely benign (Jan 29, 2024) | ||
14-75579050-C-A | Posterior column ataxia-retinitis pigmentosa syndrome | Uncertain significance (Jan 13, 2018) | ||
14-75579051-G-A | Uncertain significance (Jun 13, 2022) | |||
14-75579075-G-A | Inborn genetic diseases | Conflicting classifications of pathogenicity (May 06, 2022) | ||
14-75579107-C-T | Likely benign (May 02, 2018) | |||
14-75579128-G-T | Likely benign (Jun 07, 2022) | |||
14-75579136-C-T | Posterior column ataxia-retinitis pigmentosa syndrome • Inborn genetic diseases | Uncertain significance (Dec 27, 2023) | ||
14-75579149-CCAACCCAGTGGCTTGGCT-C | Uncertain significance (Oct 19, 2022) | |||
14-75579161-CT-C | Fowler syndrome | Likely pathogenic (Apr 20, 2023) | ||
14-75579195-C-T | Inborn genetic diseases | Uncertain significance (May 08, 2024) | ||
14-75579216-A-T | Uncertain significance (Aug 07, 2023) | |||
14-75579223-G-A | Uncertain significance (Aug 13, 2022) | |||
14-75579239-G-A | Likely benign (May 19, 2022) | |||
14-75579249-T-C | Posterior column ataxia-retinitis pigmentosa syndrome | Uncertain significance (Jan 13, 2018) | ||
14-75579258-A-G | Posterior column ataxia-retinitis pigmentosa syndrome | Conflicting classifications of pathogenicity (Oct 03, 2023) | ||
14-75579262-G-A | Inborn genetic diseases | Uncertain significance (Jul 19, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FLVCR2 | protein_coding | protein_coding | ENST00000238667 | 10 | 84598 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000343 | 0.945 | 125702 | 0 | 46 | 125748 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0642 | 293 | 296 | 0.990 | 0.0000175 | 3425 |
Missense in Polyphen | 83 | 82.298 | 1.0085 | 1003 | ||
Synonymous | -0.0521 | 122 | 121 | 1.01 | 0.00000803 | 1097 |
Loss of Function | 1.82 | 12 | 21.0 | 0.572 | 0.00000102 | 244 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000445 | 0.000445 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000185 | 0.000139 |
European (Non-Finnish) | 0.000185 | 0.000185 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000229 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as an importer of heme. Also acts as a transporter for a calcium-chelator complex, important for growth and calcium metabolism. {ECO:0000269|PubMed:20823265}.;
Recessive Scores
- pRec
- 0.147
Intolerance Scores
- loftool
- 0.633
- rvis_EVS
- 0.35
- rvis_percentile_EVS
- 74.49
Haploinsufficiency Scores
- pHI
- 0.234
- hipred
- N
- hipred_score
- 0.289
- ghis
- 0.453
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.113
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Flvcr2
- Phenotype
- immune system phenotype; embryo phenotype; respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); neoplasm; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- transmembrane transport;heme export
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- heme transporter activity;heme binding